Martin Smoragiewicz

5PUBLICATIONS
52CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.

|Nov 08, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.

Eric Winquist, Sebastien J Hotte, Kim Chi

|Oct 31, 2020
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

Daniele Biasci, Martin Smoragiewicz, Claire M Connell

|Feb 23, 2020
Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT).

Martin Smoragiewicz, Alex A Adjei, Emiliano Calvo

Pageof 1